** Shares of Australia's Nova Eye Medical Ltd EYE.AX jump
20.4% to A$0.325, their highest since April 3
** The company says U.S. sales of glaucoma surgical devices
surged 65% to $5.1 mln for 6 months
** Stock last up ~15% on the day
** It has rocketed nearly 160% in the past 8 session, incl
due to the withdrawal of proposed US Medicare changes that would
have affected glaucoma surgeries
** Nova says it expects the to accelerate US sales in H2
(Reporting by Poonam Behura in Bengaluru)
((Poonam.Behura@thomsonreuters.com;))